Additionally, within most centers there was no difference for assessing TDP-43 in participants with FTLD compared to those with AD: out of 25 centers with both participants with FTLD and participants with AD, 14 centers had identical rates of TDP-43 staining for these groups. Here, TARDBP is linked to Alzheimer disease.